Press Releases Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 03:06:19 2025-12-18 pm EST			5-day change	1st Jan Change
0.1000 ^CAD	-.--%		-.--%	-

Dec. 21	Entheon Biomedical Corp. signed a letter of intent to acquire Entheon Biomedical Corp. for CAD 5.33 million in a reverse merger transaction.	CI
25-09-22	Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2025	CI

Press Releases

Jan. 19	Entheon Announces Execution of Business Combination Agreement with Nutravisor	NE
Dec. 22	Entheon Announces Letter of Intent with Nutravisor Inc.	NE
Dec. 19	Canadian Investment Regulatory Organization Trading Halt - ENBI	AQ
25-04-04	Entheon Announces Change of Directors	NE
25-03-31	Entheon Issues Incentive Stock Options	NE
25-03-14	Entheon Announces Termination of Mentis AI Agreement	NE
25-01-24	Canadian Investment Regulatory Organization Trade Resumption - ENBI	AQ
25-01-24	Entheon Announces Agreement to Acquire Mentis AI	NE
25-01-24	Canadian Investment Regulatory Organization Trading Halt - ENBI	AQ
22-07-26	Entheon Biomedical : CFO Certification	PU
22-07-26	Entheon Biomedical : CEO Certification	PU
22-07-26	Entheon Biomedical : Quarterly Report	PU
22-03-31	Entheon Biomedical : CFO Certification	PU
22-03-30	Entheon Biomedical : CEO Certification	PU
22-03-30	Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform	AQ
21-12-03	Entheon Biomedical Announces Participation in the Benzinga Global Small Cap Conference	NE
21-11-22	BTV Investor Alert Video: Entheon Biomedical Corp. - Treating Addiction	NE
21-09-23	Microdose Psychedelic Insights Announces Entheon Biomedical, Levitee Labs, and Women in Psychedelics to take centre stage at Psychedelic Capital: September 30, 2021	NE
21-09-01	Leading DMT Companies to Take Stage at Molecular Masterclass: DMT Conference	NE
21-08-30	Entheon Biomedical : Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics	AQ
21-08-25	Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon Advisory Board	NE
21-08-24	Entheon Biomedical Corp. Announces DTC Eligibility	NE
21-08-12	Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine	NE
21-07-30	Entheon Biomedical Corp. Acquires Lobo Genetics Inc.	NE
21-07-28	Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Press Releases

Filters